Partner of Choice. By Choice.
In 2022 Inpart surveyed more than 100 biotechs worldwide for its Partnering 2030 report to determine which pharma company offered the very best partnering experience. The clear winner: AbbVie. Praised by biotechs for its good working relationships and commitment to achieving business and scientific objectives, AbbVie has established itself as a partner of choice – and it’s not by accident.
In this exclusive webinar, Niels Emmerich, Vice President and Global Head of Search & Evaluation, explains how AbbVie chose to position itself as a partner of choice for biotechs, the best practices it implemented to achieve this position, and what the company is seeking in partners in 2023 and beyond.
Watch the replay to learn:
- How important the 'first touch' is in biopharma partnering
- Effective strategies for getting your foot in the door at a top pharma company
- What partnering opportunities AbbVie is seeking in 2023